RATIONALE: Glutaminase is considered the main glutamate (Glu)-producing enzyme. Two isoforms, liver (LGA)- and kidney (KGA)-type glutaminases, have been identified in neurons. The role of both enzymes in psychopharmacological responses to cocaine remains unknown. OBJECTIVES: We examined both mRNA and protein expression of KGA and LGA in the brain of mice sensitized to cocaine. Additionally, total glutaminase activity was also measured. METHODS: Total glutaminase activity and mRNA and protein expression of KGA and LGA were measured on the dorsal striatum, prefrontal cortex, hippocampus and cerebellum of cocaine-sensitized mice. RESULTS: Cocaine-sensitized animals (20 mg/kg × 5 days, followed by 5 drug-free days) exhibited a decrease of total glutaminase activity in both the dorsal striatum and the prefrontal cortex. This was associated with an increase in KGA mRNA expression in both brain areas that was not observed when protein KGA levels were measured by western blot. LGA mRNA expression was increased as results of acute cocaine administration in sensitized animals, although protein levels were only enhanced in the prefrontal cortex of sensitized mice. These findings suggest that chronic cocaine administration modulates glutamate production through the regulation of glutaminase expression and activity. These actions are mainly observed in the prefrontal cortex-dorsal striatum circuit, the neuroanatomical target for the psychostimulant sensitization properties of cocaine. CONCLUSIONS: The present results indicate that glutaminase enzymes (mainly KGA) are modulated by cocaine in both the prefrontal cortex and the dorsal striatum, as part of the neuroadaptions associated with behavioural sensitization to this drug of abuse.
RATIONALE: Glutaminase is considered the main glutamate (Glu)-producing enzyme. Two isoforms, liver (LGA)- and kidney (KGA)-type glutaminases, have been identified in neurons. The role of both enzymes in psychopharmacological responses to cocaine remains unknown. OBJECTIVES: We examined both mRNA and protein expression of KGA and LGA in the brain of mice sensitized to cocaine. Additionally, total glutaminase activity was also measured. METHODS: Total glutaminase activity and mRNA and protein expression of KGA and LGA were measured on the dorsal striatum, prefrontal cortex, hippocampus and cerebellum of cocaine-sensitized mice. RESULTS:Cocaine-sensitized animals (20 mg/kg × 5 days, followed by 5 drug-free days) exhibited a decrease of total glutaminase activity in both the dorsal striatum and the prefrontal cortex. This was associated with an increase in KGA mRNA expression in both brain areas that was not observed when protein KGA levels were measured by western blot. LGA mRNA expression was increased as results of acute cocaine administration in sensitized animals, although protein levels were only enhanced in the prefrontal cortex of sensitized mice. These findings suggest that chronic cocaine administration modulates glutamate production through the regulation of glutaminase expression and activity. These actions are mainly observed in the prefrontal cortex-dorsal striatum circuit, the neuroanatomical target for the psychostimulant sensitization properties of cocaine. CONCLUSIONS: The present results indicate that glutaminase enzymes (mainly KGA) are modulated by cocaine in both the prefrontal cortex and the dorsal striatum, as part of the neuroadaptions associated with behavioural sensitization to this drug of abuse.
Authors: Kwang Ho Choi; Scott Edwards; Danielle L Graham; Erin B Larson; Kimberly N Whisler; Diana Simmons; Allyson K Friedman; Jessica J Walsh; Zia Rahman; Lisa M Monteggia; Amelia J Eisch; Rachael L Neve; Eric J Nestler; Ming-Hu Han; David W Self Journal: J Neurosci Date: 2011-05-25 Impact factor: 6.167
Authors: Yan Dong; Fernando J Nasif; Jennifer J Tsui; William Y Ju; Donald C Cooper; Xiu-Ti Hu; Robert C Malenka; Francis J White Journal: J Neurosci Date: 2005-01-26 Impact factor: 6.167
Authors: Koji Aoyama; Sang Won Suh; Aaron M Hamby; Jialing Liu; Wai Yee Chan; Yongmei Chen; Raymond A Swanson Journal: Nat Neurosci Date: 2005-11-27 Impact factor: 24.884
Authors: Javier Márquez; Amada R López de la Oliva; José M Matés; Juan A Segura; Francisco J Alonso Journal: Neurochem Int Date: 2006-03-03 Impact factor: 3.921
Authors: Guo-Chi Zhang; Khang Vu; Nikhil K Parelkar; Li-Min Mao; Ian M Stanford; Eugene E Fibuch; John Q Wang Journal: Neurosci Lett Date: 2008-11-08 Impact factor: 3.046
Authors: Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca Journal: Neurochem Res Date: 2016-12-23 Impact factor: 3.996
Authors: Ana Palomino; Francisco-Javier Pavón; Eduardo Blanco-Calvo; Antonia Serrano; Sergio Arrabal; Patricia Rivera; Francisco Alén; Antonio Vargas; Ainhoa Bilbao; Leticia Rubio; Fernando Rodríguez de Fonseca; Juan Suárez Journal: Front Integr Neurosci Date: 2014-03-05
Authors: Ana Carolina de Moura; Virgínia Meneghini Lazzari; Grasiela Agnes; Silvana Almeida; Márcia Giovenardi; Ana Beatriz Gorini da Veiga Journal: Einstein (Sao Paulo) Date: 2014-09
Authors: Ana Peñalver; José A Campos-Sandoval; Eduardo Blanco; Carolina Cardona; Laura Castilla; Mercedes Martín-Rufián; Guillermo Estivill-Torrús; Raquel Sánchez-Varo; Francisco J Alonso; Mercedes Pérez-Hernández; María I Colado; Antonia Gutiérrez; Fernando Rodríguez de Fonseca; Javier Márquez Journal: Front Mol Neurosci Date: 2017-09-05 Impact factor: 5.639
Authors: Karen D Ersche; Tsen Vei Lim; Alexander G Murley; Catarina Rua; Matilde M Vaghi; Tara L White; Guy B Williams; Trevor W Robbins Journal: Biol Psychiatry Date: 2020-12-19 Impact factor: 13.382